85 FR 138 pgs. 43603-43604 - Importer of Controlled Substances Application: Cambrex Charles City

Type: NOTICEVolume: 85Number: 138Pages: 43603 - 43604
Docket number: [Docket No. DEA-669]
FR document: [FR Doc. 2020-15464 Filed 7-16-20; 8:45 am]
Agency: Justice Department
Sub Agency: Drug Enforcement Administration
Official PDF Version:  PDF Version
Pages: 43603, 43604

[top] page 43603

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-669]

Importer of Controlled Substances Application: Cambrex Charles City

ACTION:

Notice of application.

DATES:

Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before August 17, 2020. Such persons may also file a written request for a hearing on the application on or before August 17, 2020.

ADDRESSES:

Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All request for a hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION:


[top] In accordance with 21 CFR 1301.34(a), this is notice that on May 6, 2020, Cambrex Charles City, 1205 11th Street, Charles City, Iowa 50616, applied to be registered as an importer of the following basic class(es) of controlled substances: page 43604

Controlled substance Drug code Schedule
4-Anilino-N-phenethyl-4-piperidine (ANPP) 8333 II
Phenylacetone 8501 II
Coca Leaves 9040 II
Opium, raw 9600 II
Poppy Straw Concentrate 9670 II

The company plans to import the listed controlled substances for internal use and to manufacture bulk intermediates for sale to its customers.

William T. McDermott,

Assistant Administrator.

[FR Doc. 2020-15464 Filed 7-16-20; 8:45 am]

BILLING CODE P>